State Street Corp Bio Rad Laboratories, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, State Street Corp holds 690,165 shares of BIO stock, worth $180 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

690,165

Previous 635,916 8.53%

Holding current value

$180 Million

Previous $213 Million 6.56%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$313.15 - $374.28 $17 Million - $20.3 Million	54,249 Added 8.53%	690,165 $227 Million
Q3 2024 Nov 14, 2024	SELL	$263.97 - $344.64 $59.1 Million - $77.2 Million	-223,975 Reduced 26.05%	635,916 $213 Million
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $3.7 Million - $4.68 Million	-13,784 Reduced 1.58%	859,891 $235 Million
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $376,792 - $436,115	-1,239 Reduced 0.14%	873,675 $302 Million
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $4.2 Million - $5.69 Million	15,591 Added 1.81%	874,914 $283 Million
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $14.4 Million - $17.4 Million	-41,250 Reduced 4.58%	859,323 $308 Million
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $7.65 Million - $10.4 Million	-21,279 Reduced 2.31%	900,573 $341 Million
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $10.9 Million - $13 Million	-25,926 Reduced 2.74%	921,852 $442 Million
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $3.84 Million - $4.98 Million	-10,926 Reduced 1.14%	947,778 $399 Million
Q3 2022 Nov 15, 2022	BUY	$412.59 - $563.26 $1.18 Million - $1.62 Million	2,869 Added 0.3%	958,704 $400 Million
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $13.3 Million - $17.1 Million	-28,697 Reduced 2.91%	955,835 $473 Million
Q1 2022 May 16, 2022	SELL	$524.57 - $735.42 $12.6 Million - $17.7 Million	-24,002 Reduced 2.38%	984,532 $555 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $18.6 Million - $20.8 Million	26,229 Added 2.67%	1,008,534 $762 Million
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $5.17 Million - $6.49 Million	7,864 Added 0.81%	982,305 $733 Million
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $1.56 Million - $1.75 Million	2,702 Added 0.28%	974,441 $628 Million
Q1 2021 May 17, 2021	SELL	$547.01 - $662.35 $3.19 Million - $3.86 Million	-5,833 Reduced 0.6%	971,739 $555 Million
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $9.62 Million - $12.1 Million	18,835 Added 1.96%	977,572 $570 Million
Q3 2020 Nov 10, 2020	BUY	$454.43 - $535.6 $14.4 Million - $17 Million	31,795 Added 3.43%	958,737 $494 Million
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $80.5 Million - $118 Million	240,255 Added 34.99%	926,942 $419 Million
Q1 2020 May 11, 2020	BUY	$320.01 - $409.07 $220 Million - $281 Million	686,687 New	686,687 $241 Million

Others Institutions Holding BIO

# of Institutions

478

Shares Held

19.2M

Call Options Held

15.7K

Put Options Held

11.5K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.43B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Bio Rad Laboratories, Inc. Transaction History